- CASI Pharmaceuticals, Inc (DE)

Dashboard

Manage Tickers Link Financial Account

CASICASI Pharmaceuticals, Inc (DE)

Nasdaq casipharmaceuticals.com

$ 2.44 $ 0.11 (4.29 %)

Friday, 26-Apr-2024 14:40:03 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 2.795

Open

$ 2.44

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.44 - $ 2.44

52 Week Range

$ 1.85 - $ 8.48

Volume

9,435

Average Volume

na

Market Cap

38.14M

Beta (5Y Monthly)

$ 0.39

PE Ratio (TTM)

nm

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	11-14-2022	09-30-2022	10-Q
2	08-12-2022	06-30-2022	10-Q
3	05-12-2022	03-31-2022	10-Q
4	03-28-2022	12-31-2021	10-K
5	11-12-2021	09-30-2021	10-Q
6	08-12-2021	06-30-2021	10-Q
7	05-13-2021	03-31-2021	10-Q
8	03-30-2021	12-31-2020	10-K
9	11-09-2020	09-30-2020	10-Q
10	08-10-2020	06-30-2020	10-Q
11	05-11-2020	03-31-2020	10-Q
12	03-16-2020	12-31-2019	10-K
13	11-12-2019	09-30-2019	10-Q
14	08-09-2019	06-30-2019	10-Q
15	05-15-2019	03-31-2019	10-Q
16	03-29-2019	12-31-2018	10-K
17	11-14-2018	09-30-2018	10-Q
18	08-14-2018	06-30-2018	10-Q
19	05-15-2018	03-31-2018	10-Q
20	03-29-2018	12-31-2017	10-K
21	11-14-2017	09-30-2017	10-Q
22	08-14-2017	06-30-2017	10-Q
23	05-15-2017	03-31-2017	10-Q
24	03-31-2017	12-31-2016	10-K
25	11-14-2016	09-30-2016	10-Q
26	08-15-2016	06-30-2016	10-Q
27	05-13-2016	03-31-2016	10-Q
28	03-28-2016	12-31-2015	10-K
29	11-13-2015	09-30-2015	10-Q
30	08-14-2015	06-30-2015	10-Q
31	05-15-2015	03-31-2015	10-Q
32	03-27-2015	12-31-2014	10-K
33	11-14-2014	09-30-2014	10-Q
34	08-14-2014	06-30-2014	10-Q
35	05-15-2014	03-31-2014	10-Q
36	03-21-2014	12-31-2013	10-K
37	11-14-2013	09-30-2013	10-Q
38	08-14-2013	06-30-2013	10-Q
39	05-15-2013	03-31-2013	10-Q
40	03-21-2013	12-31-2012	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

CASI Pharmaceuticals Discloses Material De...
04/08/2024 21:03:35

On April 8, 2024, CASI Pharmaceuticals, announced that, with respect to the Company’s previously announced dispute with Juventa...

CASI Pharmaceuticals Wins Emergency Relief...
04/08/2024 11:34:32

On April 8, 2024, CASI Pharmaceuticals, Inc., a Cayman Islands incorporated company (“CASI” or the “Company”) announced that, ...

CASI Pharmaceuticals Q4 EPS $(0.45) Misses...
03/28/2024 12:45:21

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

recap-casi-pharmaceuticals-q4-earnings

Recap: CASI Pharmaceuticals Q4 Earnings
03/28/2024 12:20:12

CASI Pharmaceuticals FY2023 GAAP EPS $(2.0...
03/28/2024 11:29:55

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(2.02) per share which missed the analyst consensus estimate o...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/08/2024 17:31:06

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/07/2024 13:06:06

casi-pharmaceuticals-blood-cancer-drug-shows-encouraging-clinical-efficacy-in-chinese-patients

CASI Pharmaceuticals Blood Cancer Drug Sho...
03/05/2024 17:16:54

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin'...

CASI Pharmaceuticals Shares Halted On Circ...
03/05/2024 14:41:21

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/05/2024 13:09:49

$casi-pharmaceuticals-report-interim-phase-1-data-for-bi-1206-in-the-treatment-of-relapsedrefractory-indolent-non-hodgkins-lymphoma-in-china$

CASI Pharmaceuticals Report Interim Phase ...
03/05/2024 12:04:08

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of ...

CASI Pharmaceuticals Reveals First Dosing ...
02/16/2024 12:13:04

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
01/25/2024 21:31:04

CASI Pharmaceuticals Has Entered Into An E...
12/08/2023 21:28:38

- SEC Filing

hc-wainwright--co-maintains-buy-rating-for-casi-pharmaceuticals-heres-what-you-need-to-know

HC Wainwright & Co. Maintains Buy Rating f...
11/15/2023 17:00:39

HC Wainwright & Co. Maintains Buy on CASI ...
11/15/2023 12:40:52

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and raises the price target...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
11/03/2023 21:31:26

why-voxx-international-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Why VOXX International Shares Are Trading ...
10/11/2023 12:24:04

Gainers

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
09/27/2023 21:31:41

HC Wainwright & Co. Reiterates Buy on CASI...
08/14/2023 10:36:53

HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $10 price ta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION